Difference between revisions of "Concluding Remarks section from DOI: 10.3390/pathogens9020148 (Q7907)"

Revision as of 20:07, 13 April 2020

Main section in the article "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148

Language	Label	Description	Also known as
English	Concluding Remarks section from DOI: 10.3390/pathogens9020148	Main section in the article "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148

Statements

instance of

Main section in publication

0 references

Segment

0 references

occurs in

Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development (DOI: 10.3390/pathogens9020148)

0 references

followed by

Table 1 - Advantages and disadvantages of different therapeutic protein production platforms (From DOI: 10.3390/pathogens9020148)

0 references

IMRaD(C) Section

Conclusion

0 references

Revision as of 20:06, 13 April 2020 Admin (talk \| contribs) (‎Created claim: followed by (P41): Table 1 - Advantages and disadvantages of different therapeutic protein production platforms (From DOI: 10.3390/pathogens9020148) (Q7908)) ← Older edit	Revision as of 20:07, 13 April 2020 Admin (talk \| contribs) (‎Created claim: IMRaD(C) Section (P124): Conclusion (Q7982)) Newer edit →
	Property / IMRaD(C) Section
	+	Conclusion
	Property / IMRaD(C) Section: Conclusion / rank
	+	Normal rank

Difference between revisions of "Concluding Remarks section from DOI: 10.3390/pathogens9020148 (Q7907)"

Revision as of 20:07, 13 April 2020

Statements

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(0 entries)

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Tools

In other languages